<DOC>
	<DOCNO>NCT00986960</DOCNO>
	<brief_summary>The purpose study evaluate whether use ACTH addition Avonex effective treatment relapse remit multiple sclerosis .</brief_summary>
	<brief_title>Effect Adrenocorticotropin Injection With Weekly Interferon Beta Patients With Relapsing Remitting Multiple Sclerosis ( MS )</brief_title>
	<detailed_description>Multiple sclerosis ( MS ) chronic , immune-mediated disease central nervous system ( CNS ) . It complex , multi-factorial disease include inflammatory neurodegenerative process manifest focally form lesion diffusely otherwise normal-appearing brain tissue . Recent data show ACTH beneficial effect specific neurodegenerative disease may superior neuroprotective effect . Adding regimen ACTH standard Avonex treatment may provide neuroprotection promote remyelination .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
	<mesh_term>beta-Endorphin</mesh_term>
	<criteria>Patient diagnose MS accord McDonald criterion Age 1865 Have RR disease course Have EDSS score 05.5 Have disease duration &lt; 20 year Suboptimal response Interferon beta1a I.M . ( Avonex® ) therapy least 6 month define : presence document relapse within last 12 month presence least one enhance T1 Gd lesion MRI perform within previous 3 month Signed informed consent Normal kidney functioning ( creatinine clearance &gt; 59 ) None exclusion criterion Presence relapse steroid treatment within 60 day prior study enrollment Presence neutralizing antibody IFNβ1a I.M . prior study enrollment Presence optic neuritis within less 6 month prior study enrollment Diagnosis osteoporosis ( T score ≥2.5 SD ) Women pregnant , lactate childbearing age consent approve contraceptive use study . Abnormal blood test , perform screen visit include : hepatitis B hepatitis C , ALT AST great two time upper limit normal , abnormal glucose fasting level already know diabetes History depression IFNβ1a I.M .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>relapse remit</keyword>
	<keyword>RRMS</keyword>
</DOC>